Clinical Trial Update: Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind trial comparing Rebamipide to Esomeprazole for NSAID-induced gastropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nsaid-induced Gastropathy

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Rebamipide (Mucosta) (rebamipide)

Snippet

Sponsor: Otsuka Pharmaceutical, Inc., Philippines | Conditions: NSAID Induced Gastropathy | Phase 4 | Status: COMPLETED